Are you attending 2026 DCAT Week in New York? We’d love to see you there! ​​​​​​ Schedule a meeting to meet our team!

Event Details

• March 23–26, 2026
• New York City, NY

Explore Our Services

We are a full spectrum CRDMO with Formulation, Analytical, and Novel Drug Delivery platforms supporting NCE, 505b(2), and ANDA products from pre-clinical through Phase III Clinical Trial Material (CTM) manufacturing and NDA/ANDA Registrations.

Our portfolio of services spans all dosage forms including Injectables, Solid orals, Capsules, Semisolids, Ophthalmics, Sterile and Nonsterile capabilities encompassing pre-formulation, drug product development, analytical method development and validation, IVRT, IVPT (Skin permeation), BABE Studies, Extractables & Leachable, Nitrosamine testing, Microbiological testing, ICH Stability Storage & testing, GLP batches, GMP clinical trial materials, scale-up, pilot, and pivotal/registration batches, and commercial manufacturing.

Bo Wang, MD Director Business Development, CMC Services

Srikanth Manne Director Scientific Strategy & Business Development, CMC Services

Shamim Rahman Senior Director Business Development CMC & Bio Analytical Services

Qun (Tony) Liu, PhD Senior Vice President U.S. Head of CDMO